Next Generation Sequencing (NGS) Global Market Demand, Growth, Opportunities, Top Key Players and Forecast to 2023

24 August, 2018

This report focuses on the global Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Sequencing (NGS) development in United States, Europe and China.

NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. This technique is also known as high throughput sequencing. 
The impact of the driving factors is expected to overcome the effect of restraints. Moreover, the utilization of cloud computing in NGS for data management and untapped emerging economies are expected to provide new market opportunities to NGS manufacturers in the near future. 
North America is estimated to command the largest share of the next-generation sequencing market in 2017, followed by Europe and Asia-Pacific. Emerging markets, like China, India, and Brazil are expected to offer significant growth opportunities owing to the improving healthcare infrastructure, government funding for translational research, and rising partnerships & agreements among market players. 
In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly. Moreover, increasing competition in mature markets will intensify the focus on emerging markets. 
In 2017, the global Next Generation Sequencing (NGS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study 
Illumina 
Thermo Fisher Scientific 
Pacific Biosciences of California 
Beijing Genomics Institute 
Qiagen 
Roche 
Agilent Technologies 
Perkinelmer 
Genomatix 
PierianDx 
Eurofins Scientific 
Gatc Biotech 
Oxford Nanopore Technologies 
Bio-Rad Laboratories 
DNASTAR 
Biomatters 
Partek 
New England Biolabs 
Myriad Genetics 
Macrogen 
GATC Biotech

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3355554-global-next-generation-sequencing-ngs-market-size-status-and-forecast-2018-2025                                 

                                     

Market segment by Type, the product can be split into 
Consumables 
Platforms 
Services

Market segment by Application, split into 
Academic & Government Research Institutes 
Pharmaceutical Companies 
Biotechnology Companies 
Hospitals & Clinics    

Market segment by Regions/Countries, this report covers 
United States 
Europe 
China 
Japan 
Southeast Asia 
India 
Central & South America

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3355554-global-next-generation-sequencing-ngs-market-size-status-and-forecast-2018-2025                         

Table Of Contents:      

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2013-2025) 
1.4.2 Consumables 
1.4.3 Platforms 
1.4.4 Services 
1.5 Market by Application 
1.5.1 Global Next Generation Sequencing (NGS) Market Share by Application (2013-2025) 
1.5.2 Academic & Government Research Institutes 
1.5.3 Pharmaceutical Companies 
1.5.4 Biotechnology Companies 
1.5.5 Hospitals & Clinics     
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 Next Generation Sequencing (NGS) Market Size 
2.2 Next Generation Sequencing (NGS) Growth Trends by Regions 
2.2.1 Next Generation Sequencing (NGS) Market Size by Regions (2013-2025) 
2.2.2 Next Generation Sequencing (NGS) Market Share by Regions (2013-2018) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities

….

12 International Players Profiles 
12.1 Illumina 
12.1.1 Illumina Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 Next Generation Sequencing (NGS) Introduction 
12.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2013-2018) 
12.1.5 Illumina Recent Development 
12.2 Thermo Fisher Scientific 
12.2.1 Thermo Fisher Scientific Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 Next Generation Sequencing (NGS) Introduction 
12.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2013-2018) 
12.2.5 Thermo Fisher Scientific Recent Development 
12.3 Pacific Biosciences of California 
12.3.1 Pacific Biosciences of California Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 Next Generation Sequencing (NGS) Introduction 
12.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2013-2018) 
12.3.5 Pacific Biosciences of California Recent Development 
12.4 Beijing Genomics Institute 
12.4.1 Beijing Genomics Institute Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 Next Generation Sequencing (NGS) Introduction 
12.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2013-2018) 
12.4.5 Beijing Genomics Institute Recent Development 
12.5 Qiagen 
12.5.1 Qiagen Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 Next Generation Sequencing (NGS) Introduction 
12.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2013-2018) 
12.5.5 Qiagen Recent Development 

 Continued…….                                                      

Start Publishing

wiseguyreports


More related article